Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor.
Sillevis Smitt
P
P
Department of Neuro-Oncology, Daniel den Hoed Cancer Center, University Hospital Rotterdam, The Netherlands. sillevis@neuh.azr.nl
Kinoshita
A
A
De Leeuw
B
B
Moll
W
W
Coesmans
M
M
Jaarsma
D
D
Henzen-Logmans
S
S
Vecht
C
C
De Zeeuw
C
C
Sekiyama
N
N
Nakanishi
S
S
Shigemoto
R
R
D000328:Adult; D000818:Animals; D001323:Autoantibodies / Q000032:analysis* / Q000097:blood / Q000134:cerebrospinal fluid; D001327:Autoimmune Diseases / Q000276:immunology*; D001921:Brain / Q000276:immunology; D016466:CHO Cells; D002524:Cerebellar Ataxia / Q000276:immunology*; D006224:Cricetinae; D005260:Female; D006689:Hodgkin Disease / Q000150:complications*; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood / Q000134:cerebrospinal fluid; D051379:Mice; D008810:Mice, Inbred C57BL; D008875:Middle Aged; D020362:Paraneoplastic Cerebellar Degeneration / Q000276:immunology*; D018094:Receptors, Metabotropic Glutamate / Q000276:immunology*
D001323:Autoantibodies; D007074:Immunoglobulin G; D018094:Receptors, Metabotropic Glutamate; C104077:metabotropic glutamate receptor type 1